Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial
β Scribed by Robert J. Motzer; Ethan Dmitrovsky; Wilson H. Miller Jr.; William P. Tong; Dean F. Bajorin; Howard I. Scher; George J. Bosl
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 523 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
over 24 hours every 21 days without growth factor support. The median age of the patients was 32.5 years (range, 18-49 years). The testis was the primary site of Genitourinary Oncology Program, Indiana Unitumor for 13 patients (72%) and the tumor was extragonadal in 5 patients (28%).
waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du Β¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the